Lisa Ann Kottschade APRN, MSN, CNP

Dr. Lisa A. Kottschade, R.N., C.N.P., is primarily interested in the treatment of malignant melanoma. She has a special interest in biomarkers as predictors of outcomes and responses of patients undergoing both adjuvant and systemic therapy for the treatment of malignant melanoma. Kottschade's current collaborative projects include looking at different methods to detect circulating BRAF in peripheral blood as a potential biomarker for monitoring patients on BRAF therapy, as well as a biomarker of recurrence.